NCT00415324 2014-05-20
Eribulin Mesylate and Cisplatin in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
Clinical Trials
12 trialsNCT00046917 2014-02-24
Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00005791 2013-12-19
Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00005996 2013-12-19
SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00003108 2013-07-18
Cisplatin Plus Bryostatin 1 in Treating Patients With Advanced Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00024323 2013-07-18
Combination Chemotherapy in Treating Patients With Advanced Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00004090 2013-07-10
Gemcitabine and Cisplatin in Treating Patients With Metastatic or Recurrent Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00012194 2013-07-09
7-hydroxystaurosporine and Cisplatin in Treating Patients With Advanced Malignant Solid Tumors
National Cancer Institute (NCI)
Phase 1 Terminated
NCT00047047 2013-06-04
Tanespimycin, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00009932 2013-05-15
Combination Chemotherapy in Treating Patients With Solid Tumors
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00006000 2013-01-31
SU5416, Irinotecan, and Cisplatin in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00004063 2009-04-30
Cisplatin, Gemcitabine, Interferon Alfa, and Hyperthermia in Treating Patients With Advanced Cancer
National Cancer Institute (NCI)
Phase 1/2 Unknown